Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamer E Fandy

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Cancer Chemotherapy and Pharmacology|December 26, 2006
Flavopiridol synergizes TRAIL cytotoxicity by downregulation of FLIPLTamer E Fandy, Douglas D Ross, Steven D Gore, et al.
Journal of Cellular and Molecular Medicine|October 27, 2022
Modulation of the activity of histone lysine methyltransferases and demethylases by curcumin analog in leukaemia cellsSuhila Sawesi, Sridhar A Malkaram, Zakaria Y Abd Elmageed, et al.
Cancer Chemotherapy and Pharmacology|December 16, 2015
In vitro characterization of transport and metabolism of the alkaloids: vincamine, vinpocetine and eburnamonineTamer E Fandy, Inas Abdallah, Maan Khayat, et al.
Neoplasia (New York, N.Y.)|July 20, 2005
Interactive effects of HDAC inhibitors and TRAIL on apoptosis are associated with changes in mitochondrial functions and expressions of cell cycle regulatory genes in multiple myelomaTamer E Fandy, Sharmila Shankar, Douglas D Ross, et al.
Pharmaceutics|March 26, 2022
COVID-19 Drug Repurposing: A Network-Based Framework for Exploring Biomedical Literature and Clinical Trials for Possible TreatmentsAhmed Abdeen Hamed, Tamer E Fandy, Karolina L Tkaczuk, et al.
Clinical Pharmacokinetics|December 1, 2017
Antibody-Drug Conjugates: Pharmacokinetic/Pharmacodynamic Modeling, Preclinical Characterization, Clinical Studies, and Lessons LearnedWilliam D Hedrich, Tamer E Fandy, Hossam M Ashour, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2014
Decitabine induces delayed reactive oxygen species (ROS) accumulation in leukemia cells and induces the expression of ROS generating enzymesTamer E Fandy, Anchalee Jiemjit, Manjusha Thakar, et al.
International Journal of Molecular Sciences|January 10, 2026
Curcuminoids Activate TET Enzymes and Increase DNA Hydroxymethylation and Active Demethylation in Leukemia CellsSridhar A Malkaram, Suhila Sawesi, Botao Peng, et al.
Pharmaceutical Research|September 5, 2014
Curcumin and dimethoxycurcumin induced epigenetic changes in leukemia cellsHazem E Hassan, Samuel Carlson, Inas Abdallah, et al.
International Journal of Molecular Medicine|November 8, 2005
Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathwaysSharmila Shankar, Thiyam R Singh, Tamer E Fandy, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Cancer Chemotherapy and Pharmacology|December 26, 2006
Flavopiridol synergizes TRAIL cytotoxicity by downregulation of FLIPLTamer E Fandy, Douglas D Ross, Steven D Gore, et al.
Journal of Cellular and Molecular Medicine|October 27, 2022
Modulation of the activity of histone lysine methyltransferases and demethylases by curcumin analog in leukaemia cellsSuhila Sawesi, Sridhar A Malkaram, Zakaria Y Abd Elmageed, et al.
Cancer Chemotherapy and Pharmacology|December 16, 2015
In vitro characterization of transport and metabolism of the alkaloids: vincamine, vinpocetine and eburnamonineTamer E Fandy, Inas Abdallah, Maan Khayat, et al.
Neoplasia (New York, N.Y.)|July 20, 2005
Interactive effects of HDAC inhibitors and TRAIL on apoptosis are associated with changes in mitochondrial functions and expressions of cell cycle regulatory genes in multiple myelomaTamer E Fandy, Sharmila Shankar, Douglas D Ross, et al.
Pharmaceutics|March 26, 2022
COVID-19 Drug Repurposing: A Network-Based Framework for Exploring Biomedical Literature and Clinical Trials for Possible TreatmentsAhmed Abdeen Hamed, Tamer E Fandy, Karolina L Tkaczuk, et al.
Clinical Pharmacokinetics|December 1, 2017
Antibody-Drug Conjugates: Pharmacokinetic/Pharmacodynamic Modeling, Preclinical Characterization, Clinical Studies, and Lessons LearnedWilliam D Hedrich, Tamer E Fandy, Hossam M Ashour, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2014
Decitabine induces delayed reactive oxygen species (ROS) accumulation in leukemia cells and induces the expression of ROS generating enzymesTamer E Fandy, Anchalee Jiemjit, Manjusha Thakar, et al.
International Journal of Molecular Sciences|January 10, 2026
Curcuminoids Activate TET Enzymes and Increase DNA Hydroxymethylation and Active Demethylation in Leukemia CellsSridhar A Malkaram, Suhila Sawesi, Botao Peng, et al.
Pharmaceutical Research|September 5, 2014
Curcumin and dimethoxycurcumin induced epigenetic changes in leukemia cellsHazem E Hassan, Samuel Carlson, Inas Abdallah, et al.
International Journal of Molecular Medicine|November 8, 2005
Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathwaysSharmila Shankar, Thiyam R Singh, Tamer E Fandy, et al.
Pageof 4